Cart
sales@molnova.com
Chelidamic acid
CAS No. 138-60-3
Chelidamic acid( —— )
Catalog No. M20536 CAS No. 138-60-3
Chelidamic acid is a heterocyclic organic acid with a pyran skeleton. Chelidamic acid is inhibitors of glutamate decarboxylase with a Ki of 33 μM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | 27 | In Stock |
|
Biological Information
-
Product NameChelidamic acid
-
NoteResearch use only, not for human use.
-
Brief DescriptionChelidamic acid is a heterocyclic organic acid with a pyran skeleton. Chelidamic acid is inhibitors of glutamate decarboxylase with a Ki of 33 μM.
-
DescriptionChelidamic acid is a heterocyclic organic acid with a pyran skeleton. Chelidamic acid is inhibitors of glutamate decarboxylase with a Ki of 33 μM.
-
In VitroChelidamic acid is a heterocyclic organic acid with a pyran skeleton. Chelidamic acid has good coordination ability with noble metal ions. Chelidamic acid is also one of the most potent inhibitors of glutamate decarboxylase, with a Ki of 33 μM.
-
In Vivo——
-
Synonyms——
-
PathwayNeuroscience
-
TargetGluR
-
RecptorGlutamate Transporters
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number138-60-3
-
Formula Weight183.12
-
Molecular FormulaC7H5NO5
-
Purity>98% (HPLC)
-
SolubilityDMSO:36 mg/mL (196.59 mM)
-
SMILESOC(=O)c1cc(=O)cc([nH]1)C(O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Porter T G Martin D L . Chelidonic acid and other conformationally restricted substrate analogues as inhibitors of rat brain glutamate decarboxylase[J]. Biochemical Pharmacology 1986 34(23):4145-4150.
molnova catalog
related products
-
1-ethyl-3-morpholin-...
1-ethyl-3-morpholin-4-yl-5,6,7,8-tetrahydroisoquinoline-4-carbonitrile is a positive allosteric modulator of mGluR3 and can be used in studies about the treatment of Parkinson's disease.
-
S-(4-Hydroxybenzyl)g...
L-γ-Glutamyl-S-[(4-hydroxyphenyl)methyl] was isolated as the major principle responsible for the inhibition of the in vitro binding of kainic acid to brain glutamate receptors by water extracts of the plant Gastrodia elata.
-
LY2608204
LY2608204 has been used in trials studying the treatment of Diabetes Mellitus, Type 2.
